Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.
about
Efficacy and tolerability of lamivudine in hepatitis B infected renal transplant recipients: A single center study.Infections in hemodialysis: a concise review. Part II: blood transmitted viral infectionsDifferential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study.Therapy for HBV Infection in Hemodialysis Patients: Is it Possible?Hepatitis B virus infection and the dialysis patient.Special populations with hepatitis B virus infection.Hepatic disorders in chronic kidney disease.Review article: Hepatitis B and dialysis.Treatment of special populations with chronic hepatitis B infection.Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.KDIGO clinical practice guideline for the care of kidney transplant recipients.Anti-HBs seroconversion during treatment with entecavir in a patient with chronic hepatitis B virus infection on hemodialysis.Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers.
P2860
Q33809854-7474DB3F-0FF5-46A7-B3C9-452C735F8319Q35532440-AFFF7484-3473-4F65-B4C8-71BD4F16FDD0Q35742711-C555AB62-9DC1-4C42-A1FD-688AB9FE0B7FQ35920128-73AD8CE3-6B1D-4AB9-B13A-A44766B51CCBQ37132310-CE49D1C6-769D-4C7C-8934-5CD154E4EF60Q37462584-E3ED4646-4F48-4C94-B529-DA5924F66F55Q37729824-C9811F9C-D5A5-434B-AA3E-8215BCBFAD5AQ37752499-0B37B709-4FBE-4DB3-9DE2-0AB021266B28Q37886158-B55D56B4-56B4-4D61-87F9-D1D0646EA227Q38168296-6D9F1EF4-9F5F-436C-B215-D084980A9D1DQ39936865-49F424BC-074D-42AD-9263-52F7886544BFQ42261578-243353A8-B42B-4B3E-8B6D-B31FC1F91EDAQ43678974-F1ECB5BB-58E7-4463-94E8-1F5D98A6D8BDQ43751294-5A2C55C1-D8BF-4FA6-BD10-DE248A9A0CEE
P2860
Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Efficiency and safety of lamiv ...... after kidney transplantation.
@ast
Efficiency and safety of lamiv ...... after kidney transplantation.
@en
Efficiency and safety of lamiv ...... after kidney transplantation.
@nl
type
label
Efficiency and safety of lamiv ...... after kidney transplantation.
@ast
Efficiency and safety of lamiv ...... after kidney transplantation.
@en
Efficiency and safety of lamiv ...... after kidney transplantation.
@nl
prefLabel
Efficiency and safety of lamiv ...... after kidney transplantation.
@ast
Efficiency and safety of lamiv ...... after kidney transplantation.
@en
Efficiency and safety of lamiv ...... after kidney transplantation.
@nl
P2860
P50
P356
P1476
Efficiency and safety of lamiv ...... r after kidney transplantation
@en
P2093
Malgorzata Michalewicz
Oksana Kowalczuk
P2860
P304
P356
10.3748/WJG.V11.I3.400
P407
P577
2005-01-01T00:00:00Z